Selective targeting of T cell subsets: focus on alefacept – a remittive therapy for psoriasis

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.4, 2002-04, pp. : 431-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab

By Cather Jennifer Clay Cather J Christian Menter Alan

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Improving T cell therapy for cancer

By Foster Aaron E Rooney Cliona M

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 215-229

Informa Healthcare

Access to resources Recommend Favorite

Adoptive T-cell therapy for the treatment of solid tumours

By Knutson Keith L Almand Bond Mankoff David A Schiffman Kathy Disis Mary L

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

Enhanced T cell receptor gene therapy for cancer

By Kieback Elisa Uckert Wolfgang

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 749-762

Informa Healthcare

Access to resources Recommend Favorite

T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy

By Bobisse Sara Zanovello Paola Rosato Antonio

Expert Opinion on Biological Therapy, Vol. 7, Iss. 6, 2007-06 ,pp. : 893-906

Informa Healthcare

Access to resources Recommend Favorite